171 related articles for article (PubMed ID: 34555519)
1. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis.
Rich NE; Phen S; Desai N; Mittal S; Yopp AC; Yang JD; Marrero JA; Iyengar P; Infante RE; Singal AG
Clin Gastroenterol Hepatol; 2022 May; 20(5):e1157-e1169. PubMed ID: 34555519
[TBL] [Abstract][Full Text] [Related]
2. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.
Rich NE; Murphy CC; Yopp AC; Tiro J; Marrero JA; Singal AG
Aliment Pharmacol Ther; 2020 Aug; 52(4):701-709. PubMed ID: 32598091
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
4. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance.
Jang S; Jin YJ; Lee JW; Kwon D; Yu JH
Medicine (Baltimore); 2023 Aug; 102(32):e34637. PubMed ID: 37565915
[TBL] [Abstract][Full Text] [Related]
6. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V;
Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836
[TBL] [Abstract][Full Text] [Related]
8. Utilization of screening for hepatocellular carcinoma in the United States.
Davila JA; Weston A; Smalley W; El-Serag HB
J Clin Gastroenterol; 2007 Sep; 41(8):777-82. PubMed ID: 17700427
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma.
Rao A; Rich NE; Marrero JA; Yopp AC; Singal AG
J Natl Compr Canc Netw; 2021 May; 19(9):1063-1071. PubMed ID: 34077908
[TBL] [Abstract][Full Text] [Related]
10. Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies.
Mair RD; Valenzuela A; Ha NB; Ayoub WS; Daugherty T; Lutchman GA; Garcia G; Ahmed A; Nguyen MH
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1412-7. PubMed ID: 22902757
[TBL] [Abstract][Full Text] [Related]
11. Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study.
Pinato DJ; Allara E; Chen TY; Trevisani F; Minguez B; Zoli M; Harris M; Dalla Pria A; Merchante N; Platt H; Jain M; Caturelli E; Kikuchi L; Pineda J; Nelson M; Farinati F; Rapaccini GL; Aytaman A; Yin M; Tan CK; Bower M; Giannini EG; Bräu N;
J Clin Oncol; 2019 Feb; 37(4):296-304. PubMed ID: 30562130
[TBL] [Abstract][Full Text] [Related]
12. Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma.
deLemos AS; Zhao J; Patel M; Kooken B; Mathur K; Nguyen HM; Mazhar A; McCarter M; Burney H; Kettler C; Chalasani N; Gawrieh S
World J Hepatol; 2024 Mar; 16(3):393-404. PubMed ID: 38577534
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection.
Akaoka M; Haruki K; Taniai T; Yanagaki M; Igarashi Y; Furukawa K; Onda S; Tsunematsu M; Shirai Y; Okui N; Gocho T; Ikegami T
Surg Oncol; 2022 Dec; 45():101881. PubMed ID: 36371905
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis.
Yang JD; Luu M; Singal AG; Noureddin M; Kuo A; Ayoub WS; Sundaram V; Kotler H; Kim IK; Todo T; Voidonikolas G; Brennan TV; Kosari K; Klein AS; Hendifar A; Lu SC; Nissen NN; Gong J
J Natl Compr Canc Netw; 2020 Sep; 18(9):1210-1220. PubMed ID: 32886898
[TBL] [Abstract][Full Text] [Related]
15. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
16. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
Khalaf N; Ying J; Mittal S; Temple S; Kanwal F; Davila J; El-Serag HB
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):273-281.e1. PubMed ID: 27521507
[TBL] [Abstract][Full Text] [Related]
17. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.
Chang PE; Ong WC; Lui HF; Tan CK
J Gastroenterol; 2008; 43(11):881-8. PubMed ID: 19012042
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.
Huo TI; Hsu CY; Huang YH; Hsia CY; Lin HC; Lee PC; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2010 Feb; 30(2):198-207. PubMed ID: 19849777
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
